Abstract:Tuberculosis (TB), caused by respiratory infection with Mycobacterium tuberculosis , remains a major global health threat. The only licensed TB vaccine, the one-hundred-year-old Bacille Calmette-Guérin has variable efficacy and often provides poor protection against adult pulmonary TB, the transmissible form of the disease. Thus, the lack of an optimal TB vaccine is one of the key barriers to TB control. Recently, the development of highly efficacious COVID-19 vaccines within one year accelerated the vaccine development process in human use, with the notable example of mRNA vaccines and adenovirus-vectored vaccines, and increased the public acceptance of the concept of the controlled human challenge model. In the TB vaccine field, recent progress also facilitated the deployment of an effective TB vaccine. In this review, we provide an update on the current virus-vectored TB vaccine pipeline and summarize the latest findings that might facilitate TB vaccine development. In detail, on the one hand, we provide a systematic literature review of the virus-vectored TB vaccines are in clinical trials, and other promising candidate vaccines at an earlier stage of development are being evaluated in preclinical animal models. These research sharply increase the likelihood of finding a more effective TB vaccine in the near future. On the other hand, we provide an update on the latest tools and concept that facilitating TB vaccine research development. We propose that a pre-requisite for successful development may be a better understanding of both the lung-resident memory T cell-mediated mucosal immunity and the trained immunity of phagocytic cells. Such knowledge could reveal novel targets and result in the innovative vaccine designs that may be needed for a quantum leap forward in vaccine efficacy. We also summarized the research on controlled human infection and ultra-low-dose aerosol infection murine models, which may provide more realistic assessments of vaccine utility at earlier stages. In addition, we believe that the success in the ongoing efforts to identify correlates of protection would be a game-changer for streamlining the triage of multiple next-generation TB vaccine candidates. Thus, with more advanced knowledge of TB vaccine research, we remain hopeful that a more effective TB vaccine will eventually be developed in the near future.

Vaccine development: obligate intracellular bacteria new tools, old pathogens: the current state of vaccines against obligate intracellular bacteria

Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections

Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria

New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity

Methods and Clinical Development of Adenovirus-Vectored Vaccines Against Mucosal Pathogens

Exploring the journey: A comprehensive review of vaccine development against Klebsiella pneumoniae

Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections

Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines

Vaccine development for bacterial pathogens: advances, challenges and prospects

Current Stage in the Development of Klebsiella pneumoniae Vaccines

Vaccine development for enteric bacterial pathogens: Where do we stand?

The Evolution of Vaccines Development across Salmonella Serovars among Animal Hosts: A Systematic Review

Advanced technologies for the development of infectious disease vaccines

Seventy Years of Chlamydia Vaccine Research – Limitations of the Past and Directions for the Future

A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19

The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline

Advances in Vaccine Development for Chlamydia trachomatis

Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections

Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development

It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity

Plague Vaccine Development: Current Research and Future Trends